vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and FIRSTSUN CAPITAL BANCORP (FSUN). Click either name above to swap in a different company.
FIRSTSUN CAPITAL BANCORP is the larger business by last-quarter revenue ($110.0M vs $77.6M, roughly 1.4× Bioceres Crop Solutions Corp.). FIRSTSUN CAPITAL BANCORP runs the higher net margin — 19.6% vs -9.6%, a 29.2% gap on every dollar of revenue. Over the past eight quarters, FIRSTSUN CAPITAL BANCORP's revenue compounded faster (6.9% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
FirstSun Capital Bancorp is a U.S.-headquartered financial holding company that offers a comprehensive range of banking and financial services, including commercial and consumer lending, deposit products, wealth management, and treasury solutions. It mainly serves individual customers, small and medium-sized enterprises, and corporate clients across U.S. regional markets.
BIOX vs FSUN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $110.0M |
| Net Profit | $-7.4M | $21.6M |
| Gross Margin | 46.8% | — |
| Operating Margin | 9.3% | — |
| Net Margin | -9.6% | 19.6% |
| Revenue YoY | -16.8% | — |
| Net Profit YoY | -20.2% | -8.4% |
| EPS (diluted) | $-0.12 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $110.0M | ||
| Q4 25 | — | $110.2M | ||
| Q3 25 | $77.6M | $107.3M | ||
| Q2 25 | — | $105.6M | ||
| Q1 25 | $60.6M | $96.2M | ||
| Q4 24 | $98.8M | $98.7M | ||
| Q3 24 | $93.3M | $98.2M | ||
| Q2 24 | — | $96.2M |
| Q1 26 | — | $21.6M | ||
| Q4 25 | — | $24.8M | ||
| Q3 25 | $-7.4M | $23.2M | ||
| Q2 25 | — | $26.4M | ||
| Q1 25 | $-1.6M | $23.6M | ||
| Q4 24 | $605.2K | $16.4M | ||
| Q3 24 | $-6.2M | $22.4M | ||
| Q2 24 | — | $24.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 46.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 39.4% | — | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 29.0% | ||
| Q3 25 | 9.3% | 26.4% | ||
| Q2 25 | — | 31.2% | ||
| Q1 25 | 1.5% | 30.9% | ||
| Q4 24 | 14.5% | 20.4% | ||
| Q3 24 | 2.5% | 29.1% | ||
| Q2 24 | — | 32.3% |
| Q1 26 | — | 19.6% | ||
| Q4 25 | — | 22.5% | ||
| Q3 25 | -9.6% | 21.6% | ||
| Q2 25 | — | 25.0% | ||
| Q1 25 | -2.6% | 24.5% | ||
| Q4 24 | 0.6% | 16.6% | ||
| Q3 24 | -6.6% | 22.8% | ||
| Q2 24 | — | 25.5% |
| Q1 26 | — | $0.76 | ||
| Q4 25 | — | $0.89 | ||
| Q3 25 | $-0.12 | $0.82 | ||
| Q2 25 | — | $0.93 | ||
| Q1 25 | $-0.02 | $0.83 | ||
| Q4 24 | $0.00 | $0.57 | ||
| Q3 24 | $-0.10 | $0.79 | ||
| Q2 24 | — | $0.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $413.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $288.3M | $1.2B |
| Total Assets | $734.9M | $8.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $413.7M | ||
| Q4 25 | — | $652.6M | ||
| Q3 25 | $15.5M | $659.9M | ||
| Q2 25 | — | $785.1M | ||
| Q1 25 | $38.5M | $621.4M | ||
| Q4 24 | $29.2M | $615.9M | ||
| Q3 24 | $32.3M | $573.7M | ||
| Q2 24 | — | $535.8M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | $288.3M | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | $345.0M | $1.1B | ||
| Q4 24 | $346.3M | $1.0B | ||
| Q3 24 | $346.0M | $1.0B | ||
| Q2 24 | — | $996.6M |
| Q1 26 | — | $8.6B | ||
| Q4 25 | — | $8.5B | ||
| Q3 25 | $734.9M | $8.5B | ||
| Q2 25 | — | $8.4B | ||
| Q1 25 | $798.2M | $8.2B | ||
| Q4 24 | $835.2M | $8.1B | ||
| Q3 24 | $827.3M | $8.1B | ||
| Q2 24 | — | $8.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $111.5M | ||
| Q3 25 | $14.4M | $49.4M | ||
| Q2 25 | — | $15.0M | ||
| Q1 25 | $23.3M | $26.4M | ||
| Q4 24 | $-5.4M | $101.1M | ||
| Q3 24 | $5.2M | $48.1M | ||
| Q2 24 | — | $20.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $104.0M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | — | $13.0M | ||
| Q1 25 | — | $24.3M | ||
| Q4 24 | — | $95.7M | ||
| Q3 24 | — | $47.1M | ||
| Q2 24 | — | $19.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 94.3% | ||
| Q3 25 | — | 44.4% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | — | 25.3% | ||
| Q4 24 | — | 97.0% | ||
| Q3 24 | — | 47.9% | ||
| Q2 24 | — | 20.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 5.5% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.49× | ||
| Q3 25 | — | 2.13× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | -8.85× | 6.18× | ||
| Q3 24 | — | 2.15× | ||
| Q2 24 | — | 0.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
